Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Oncotarget|June 18, 2015
Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?Sameh Mikhail, Kristen Ciombor, Anne Noonan, et al.Therapeutic Advances in Medical Oncology|February 17, 2017
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysisDaniel H Ahn, Kavya Krishna, Marlo Blazer, et al.Cancer Treatment and Research Communications|February 20, 2021
Impact of high-risk features for stage II adenocarcinoma of the appendixMehmet Akce, Katerina Zakka, McKenna Penley, et al.Journal of Surgical Oncology|October 30, 2020
Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomesOlatunji B Alese, Katerina Zakka, Xingyue Huo, et al.European Journal of Heart Failure|September 20, 2012
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantationChristina Wu, Tomoko S Kato, Katherine Pronschinske, et al.Leukemia|December 2, 2016
Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinibJ Yu, L Chen, B Cui, et al.Oncology|January 25, 2022
Comparing Somatostatin Analogs in the Treatment of Advanced Gastroenteropancreatic Neuroendocrine TumorsMohammed B Allaw, Jeffrey M Switchenko, Lana Khalil, et al.Surgical Oncology|December 28, 2020
Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix?Katerina Zakka, Shayla Williamson, Renjian Jiang, et al.JCO Oncology Practice|March 12, 2020
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer Living With HIV: A Perspective on Recent Progress and Future NeedsIbrahim Halil Sahin, Sujata R Kane, Edith Brutcher, et al.Journal of Hepatocellular Carcinoma|August 16, 2019
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinomaKaterina Zakka, Renjian Jiang, Olatunji B Alese, et al.Pageof 14